BETHANECHOL

Course overview

BETHANECHOL IS FDA APPROVED FOR THE TREATMENT OF POSTOPERATIVE URINARY RETENTION, POSTPARTUM URINARY RETENTION, AND OVERFLOW INCONTINENCE CAUSED BY NEUROGENIC ATONY OF THE BLADDER. IT IS IN THE PARASYMPATHOMIMETIC CLASS OF DRUGS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR BETHANECHOL AS A VALUABLE AGENT IN THE MANAGEMENT OF NONOBSTRUCTIVE URINARY RETENTION RELATED DISORDERS WHEN APPLICABLE. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS PERTINENT TO MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH NONOBSTRUCTIVE URINARY RETENTION AND RELATED CONDITIONS.